POST MARKETING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SOLIFENACIN IN PATIENTS WITH OAB (OVERACTIVE BLADDER) AFTER TURP (TRANS-URETHRAL RESECTION OF PROSTATE) OR PVP (PHOTOSELECTIVE VAPORIZATION OF PROSTATE):